- Home
- VCNX vs NVFY Comparison
VCNX vs NVFY Comparison
Compare VCNX & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCNX
- NVFY
- Stock Information
- Founded
- VCNX 2001
- NVFY 2003
- Country
- VCNX United States
- NVFY United States
- Employees
- VCNX N/A
- NVFY N/A
- Industry
- VCNX Biotechnology: Pharmaceutical Preparations
- NVFY Home Furnishings
- Sector
- VCNX Health Care
- NVFY Consumer Discretionary
- Exchange
- VCNX Nasdaq
- NVFY Nasdaq
- Market Cap
- VCNX 4.5M
- NVFY 3.6M
- IPO Year
- VCNX N/A
- NVFY N/A
- Fundamental
- Price
- VCNX $3.22
- NVFY $0.70
- Analyst Decision
- VCNX
- NVFY
- Analyst Count
- VCNX 0
- NVFY 0
- Target Price
- VCNX N/A
- NVFY N/A
- AVG Volume (30 Days)
- VCNX 167.3K
- NVFY 45.5K
- Earning Date
- VCNX 11-29-2024
- NVFY 11-14-2024
- Dividend Yield
- VCNX N/A
- NVFY N/A
- EPS Growth
- VCNX N/A
- NVFY N/A
- EPS
- VCNX N/A
- NVFY N/A
- Revenue
- VCNX $388,000.00
- NVFY $9,955,064.00
- Revenue This Year
- VCNX N/A
- NVFY N/A
- Revenue Next Year
- VCNX N/A
- NVFY N/A
- P/E Ratio
- VCNX N/A
- NVFY N/A
- Revenue Growth
- VCNX N/A
- NVFY N/A
- 52 Week Low
- VCNX $1.39
- NVFY $0.67
- 52 Week High
- VCNX $13.02
- NVFY $6.38
- Technical
- Relative Strength Index (RSI)
- VCNX 48.87
- NVFY 27.15
- Support Level
- VCNX $2.87
- NVFY $0.90
- Resistance Level
- VCNX $3.43
- NVFY $1.17
- Average True Range (ATR)
- VCNX 0.53
- NVFY 0.11
- MACD
- VCNX 0.05
- NVFY -0.03
- Stochastic Oscillator
- VCNX 23.22
- NVFY 5.64
About VCNX Vaccinex Inc.
Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. The firm has also developed a proprietary drug discovery platform, ActivMAb.
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.